ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1268

Long-Term Follow-Up Of a Pediatric Lupus Cohort: Transition Of Care and Health Related Outcomes

Susanna Felsenstein1, Anusha Ramanathan2, Beatriz Gonzalez3 and Andreas Reiff4, 1Pediatric Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, 2Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, 3Pediatric Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, 4Division of Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: pediatrics and systemic lupus erythematosus (SLE), Transition

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects II: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Transition from pediatric to adult care is a difficult process with the potential for negative impact on medical, psychological and social outcomes.  In this study we assessed the social and health related outcomes of a cohort of pSLE patients transitioned to adult care. 

Methods: We conducted a cross-sectional observational survey based on a telephone questionnaire of young adults with pSLE diagnosed and treated at Children’s Hospital Los Angeles between 1992 and 2007. All patients met ACR criteria for SLE at diagnosis and had originally participated in a SLE genetic study prior to their transition. Outcome measures were self-reported survey responses related to transition of care, medication knowledge and adherence, employment status and disease related damage. 

Results:

After an average follow-up period of 5 years since transition (SD 3.7 years) 51 of the original 150 pSLE patients could be contacted of whom 41 consented to participate in the study. 2 were deceased. Median age at the time of interview was 24 years (range 18-34 years), median disease duration was 11.2 years (range 6-21 years), The patients were primarily female (90%) and Hispanic (71%). A significantly lower need for hospitalizations was seen in those patients who had been referred to the adult physician by their pediatric rheumatologist (8/18; 44%), compared to those who had no assistance in the referral process (15/19; 56%), (p=0.04). 38/41(93%) reported that they saw a physician regularly, 35/41 (85%) a rheumatologist. 20/41 (49%) had had an appointment with a physician within the last month, 16/41 (39%) within the last 6 months. Three patients (2 with active disease) had no regular interaction with a medical professional at all.  22/41(54%) of patients experienced difficulties with the transition process; 13/41 (31.7%) due to loss of insurance and 10/41 (24%) reported difficulties due to emotional readjustment. Patients reported taking on average 4 medications and 78% reported full compliance. Compliance did not increase with age or extent of end-organ involvement. 16/41 (39%) of patients were unemployed, and 9/16 (56%) of those reported this to be lupus-related (p=0.01). At the time of the interview 37/41 (90%) of patients reported symptoms with involvement of 3 or more organ systems in two thirds.  Most symptoms were mild and managed as an outpatient and 34/41 (83%) felt their lupus was under good control. 9/24 (37.5%) with renal involvement at disease onset had undergone or were awaiting renal transplant and (36%) reported either new or ongoing neuropsychiatric symptoms which were associated with unemployment (10/15 vs 6/26; p=0.009).

Conclusion:

The majority of our patients successfully transitioned from pediatric to adult rheumatologic care. However frequent challenges during transition were  loss of insurance and emotional attachments to the former pediatric provider. This highlights the importance of a structured transition process by pediatric rheumatologists to their adult colleagues including preparation for the emotional readjustment and guidance for financial and insurance matters.  Morbidity remains high in pSLE through adulthood, with renal and CNS manifestations as the leading cause for disease related unemployment.


Disclosure:

S. Felsenstein,
None;

A. Ramanathan,
None;

B. Gonzalez,
None;

A. Reiff,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-term-follow-up-of-a-pediatric-lupus-cohort-transition-of-care-and-health-related-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology